SCHEMBL10047317

SCHEMBL10047317

Cc1ccc(S(=O)(=O)N=Cc2ccc(C)o2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 5/20 0.62
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ RECQL P46063 1/20 0.62
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ ALDH1A1 P00352 5/20 0.54
▸ GAA P10253 3/20 0.50
▸ LMNA P02545 2/20 0.50
▸ PKM P14618 1/20 0.49
▸ HTT P42858 3/20 0.48
▸ MAPT P10636 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ ATM Q13315 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ F2 P00734 1/20 0.41
▸ PRSS1 P07477 1/20 0.41
▸ PRSS2 P07478 1/20 0.41
▸ PRSS3 P35030 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12444223 1.00 POLB (0.62) POLBMEN1KMT2ARECQLL3MBTL1
SCHEMBL29219636 0.80 POLB (0.57) POLBMEN1KMT2ARECQLL3MBTL1
SCHEMBL29219632 0.80 POLB (0.57) POLBMEN1KMT2ARECQLL3MBTL1
SCHEMBL307938 0.79 ALDH1A1 (0.78) POLBMEN1KMT2AALDH1A1GAA
SCHEMBL16802983 0.79 ALDH1A1 (0.78) POLBMEN1KMT2AALDH1A1GAA
SCHEMBL10073012 0.79 ALDH1A1 (0.78) POLBMEN1KMT2AALDH1A1GAA
SCHEMBL5960097 0.76 POLB (1.00) POLBMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL5960093 0.76 POLB (1.00) POLBMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL3104931 0.75 ALDH1A1 (0.67) POLBMEN1KMT2AALDH1A1GAA
SCHEMBL1933186 0.75 ALDH1A1 (0.67) POLBMEN1KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 — — US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB POLB 2318/4885MEN1 1515/4885KMT2A 2919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback